- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03690128
Individual Early Warning Score (I-EWS)
Individual Early Warning Score (I-EWS) - Does Clinical Assessment Improve Detection of Acute Deterioration in Hospitalized Patients - a Cluster-randomized Trial
Study Overview
Status
Conditions
Detailed Description
Every year more than 250,000 patients are admitted in the Capital Region of Denmark. During admissions, the clinical track and trigger system "Early Warning Score" (EWS) is used to systematically observe and detect acutely deteriorating patients. The system is designed to prevent serious adverse events like unanticipated transfer to the intensive care unit, cardiac arrest and unexpected death. EWS consists of standardized measurements of the patient's vital signs and an escalation protocol that determines further actions based on the aggregated EWS score. At admission, and as a minimum twice a day, nurses measure vital signs on all hospitalized patients. Depending on the predetermined cut-off values (i.e. heart rate above 150 bpm = 3 points) an aggregated score is calculated. Based on the total score, the escalation protocol determines the time interval for the next measurement as well as a clinical action (i.e. call for attending doctor). EWS is developed to detect and to treat potentially deterioration of disease that might lead to critical illness and death. In its current form, there is only limited room for individual clinical assessment.
A standardized track and trigger system like EWS does not differentiate between different types of disease or the patient's individual physiological response. Therefore, there is a potential risk that the system fails to detect a patient with an abnormal stress response. Additionally; patients suffering from chronic illness might have different normal values than healthy patients, leading to unnecessarily excess observation, measurement, and suboptimal usage of limited staff resources.
Previous studies have shown that Early Warning System scores perform well for prediction of cardiac arrest and death within 48 hours, although the impact on health outcomes and resource utilization remains uncertain, often owing to methological limitations.
It is possible, but never studied before, whether the combination of vital signs with individual clinical assessment is a better tool for identifying hospitalized high-risk patients than the existing algorithms.
Further improvement and optimizing of the EWS is necessary, as there is potential to improve patient care and use staff resources more appropriate.
The purpose of the study is to investigate the impact of the I-EWS that has a systematic involvement of clinical assessment and the possibility to adjust the score, whilst keeping the same escalation protocol. I-EWS will be compared to the existing EWS with a focus on mortality, critical illness, and the use of staff resources.
Our hypothesis is that I-EWS, where clinical assessment is given a more prominent role will not increase the mortality among hospitalized patients but can reallocate personnel resources.
I-EWS is built in to electronic patient journal system "Sundhedsplatformen" it is only available in Sundhedsplatformen (SP) at hospitals assigned to I-EWS. Four hospitals are randomized to use I-EWS for 6,5 months, the remaining four hospitals are control hospitals using the current EWS in this period.
After 6,5 months a single cross-over will be preformed, and the previous control hospitals will use I-EWS over the next 6,5 months and the previous intervention hospitals, will go back to the current EWS for this period.
EWS scores and subsequent actions are documented in real time in SP. The first two weeks and final four weeks of each period will be excluded due to a implementation period. Data regarding patients, interventions and serious adverse events during hospitalization (i.e., cardiac arrest, the request of MET or unexpected death) will be accessed through SP and the Danish Central Registries (The Danish National Patient Registry, the Civil Registration System, DanArrest). After extraction, all data will be depersonalization and stored at a secured network in accordance with the current guidelines for data management in the Capital Region of Denmark.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Capital Region Of Denmark
-
Copenhagen, Capital Region Of Denmark, Denmark, 2400
- Bispebjerg Hospital
-
Copenhagen, Capital Region Of Denmark, Denmark, 2650
- Amager & Hvidovre Hospital
-
Copenhagen, Capital Region Of Denmark, Denmark, 2730
- Herlev & Gentofte Hospital
-
Glostrup, Capital Region Of Denmark, Denmark, 2600
- Rigshospital, Glostrup, Medical Ward
-
Hillerød, Capital Region Of Denmark, Denmark, 3400
- Nordsjaellands Hospital
-
-
Region Of Zealand
-
Holbæk, Region Of Zealand, Denmark, 4300
- Holbaek Hospital
-
Roskilde, Region Of Zealand, Denmark, 4000
- Zealand University Hospital (Roskilde & Køge)
-
Slagelse, Region Of Zealand, Denmark, 4200
- Slagelse Sygehus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All patients ≥18 years of age admitted more than 24 hours to a ward at participating hospitals will be included.
Participating hospitals are
- Herlev & Gentofte Hospital
- Nordsjaellands Hospital
- Bispebjerg Hospital
- Rigshospitalet, Glostrup - Medical Ward
- Amager & Hvidovre Hospital
- Zealand University Hospital
- Slagelse Hospital
- Holbaek Hospital
Exclusion Criteria:
- Wards not using standard EWS, paediatric, obstetric and intensive, due to they use special variations (Pediatric early warning score, Obstetric Early warning Score or continous monitoring).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control Arm - standard EWS procedure
Standard use of the current implement Early Warning System, based on the principles of the National Early Warning Score and with a standard escalation protocol.
|
Standard EWS - Based on principles of National Early Warning Score (NEWS)
|
|
Active Comparator: Intervention Arm - I-EWS
Implementation of Individual Early Warning Score (I-EWS) with a systematic clinical assessment with a standard escalation protocol as intervention 7 parameters (Respiration rate, pulse, saturation, systolic blood pressure, consciousness, temperature, Oxygen) are registered , an aggregated score is generated. In the electronic patient journal (Sundhedsplatformen), the nursing staff is asked to reevaluate the aggregated score based on their clinical assessment of the patient. The aggregated score can be upgraded with up to 6 points and downgraded with up to 4. This new I-EWS score interacts with the standard escalation protocol which defines the observation frequency and relevant clinical actions. |
In relation to systematic measurement of vital parameters the nursing staff will perform an individual clinical assessment of the patient and adjust the I-EWS score accordingly.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
All Cause mortality at 30 days
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
The number of NEWS/I-EWS scores per patient per day
Time Frame: Assessed after one year, after completion of the study
|
Assessed after one year, after completion of the study
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Length of hospital stay
Time Frame: 30 days
|
Calculated as days from date of index admission to date of discharge
|
30 days
|
|
All Cause mortality at 2 days
Time Frame: 2 days (48 hours) after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
2 days (48 hours) after index admission
|
|
All Cause mortality at 7 days
Time Frame: 7 days (168 hours) after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
7 days (168 hours) after index admission
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Frequency of changes in I-EWS scores that lead to an escalation or de-escalation in the escalation protocol
Time Frame: Assessed after one year, after completion of the study
|
Assessed after one year, after completion of the study
|
|
|
Comparison of changes in EWS score due to I-EWS modification (intervention group) and due to temporary or chronic acceptable values (control group)
Time Frame: Assessed after one year, after completion of the study
|
Assessed after one year, after completion of the study
|
|
|
The number of Cardiac arrests* during hospital stay, reported in numbers (%)
Time Frame: Assessed after one year, after completion of the study
|
*Definition - Presence of a clinical cardiac arrest (as defined in the resuscitation guidelines) in patients without a DNAR (Do Not Attempt Resuscitation) order.
Registered in DANARREST.
|
Assessed after one year, after completion of the study
|
|
The number of Cardiac arrests* during hospital stay, reported in number per 10,000 ward days
Time Frame: Assessed after one year, after completion of the study
|
*Definition - Presence of a clinical cardiac arrest (as defined in the resuscitation guidelines) in patients without a DNAR (Do Not Attempt Resuscitation) order.
Registered in DANARREST.
|
Assessed after one year, after completion of the study
|
|
Scores generating a call for Mobile Emergency team (MET) reported in absolute number (%)
Time Frame: Assessed after one year, after completion of the study
|
Assessed after one year, after completion of the study
|
|
|
Scores generating a call for Mobile Emergency team (MET) reported in absolute per 10,000 ward days
Time Frame: Assessed after one year, after completion of the study
|
Assessed after one year, after completion of the study
|
|
|
Scores generating a call for the attending doctor, reported in absolute number (%)
Time Frame: Assessed after one year, after completion of the study
|
Assessed after one year, after completion of the study
|
|
|
Scores generating a call for the attending doctor, reported per 10,000 ward days
Time Frame: Assessed after one year, after completion of the study
|
Assessed after one year, after completion of the study
|
|
|
All cause mortality - Subgroup analysis of patients admitted to Herlev-Gentofte Hospital
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
All cause mortality - Subgroup analysis of patients admitted to Nordsjaellands Hospital
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
All cause mortality - Subgroup analysis of patients admitted to Bispebjerg Hospital
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
All cause mortality - Subgroup analysis of patients admitted to Glostrup Hospital (Medical Ward)
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
All cause mortality - Subgroup analysis of patients admitted to Amager-Hvidovre Hospital
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
All cause mortality - Subgroup analysis of patients admitted to Zealand University Hospital
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
All cause mortality - Subgroup analysis of patients admitted to Slagelse Hospital
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
All cause mortality - Subgroup analysis of patients admitted to Holbaek Hospital
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
All cause mortality - Subgroup analysis of patients Age ≤ 39 years
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
All cause mortality - Subgroup analysis of patients Age 40 to 69 years
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
All cause mortality - Subgroup analysis of patients Age ≥ 70 years
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
All cause mortality - Subgroup analysis of patients diagnosed with cardiovascular disease
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
All cause mortality - Subgroup analysis of patients diagnosed with cancer disease
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
All cause mortality - Subgroup analysis of patients diagnosed with pulmonary disease
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
All cause mortality - Subgroup analysis of patients diagnosed with infectious disease
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
All cause mortality - Subgroup analysis of patients diagnosed with neurological disease
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
All cause mortality - Subgroup analysis of patients diagnosed with surgical condition
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients admitted to Herlev-Gentofte Hospital
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients admitted to Nordsjaellands Hospital
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients admitted to Bispebjerg Hospital
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients admitted to Amager-Hvidovre Hospital
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients admitted to Zealand University Hospital
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients admitted to Slagelse Hospital
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients admitted to Holbaek Hospital
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients Age ≤ 39 years
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients Age 40 to 69 years
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients Age ≥ 70 years
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients diagnosed with cancer
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients diagnosed with cardiovascular disease
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients diagnosed with pulmonary disease
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients diagnosed with infectious disease
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients diagnosed with neurological disease
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
|
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients diagnosed with surgical condition
Time Frame: 30 days after index admission
|
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
|
30 days after index admission
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Kasper Iversen, MD, DMSci, Department of Cardiology, Herlev Hospital
Publications and helpful links
General Publications
- Nielsen PB, Langkjaer CS, Schultz M, Kodal AM, Pedersen NE, Petersen JA, Lange T, Arvig MD, Meyhoff CS, Bestle MH, Holge-Hazelton B, Bunkenborg G, Lippert A, Andersen O, Rasmussen LS, Iversen KK. Clinical assessment as a part of an early warning score-a Danish cluster-randomised, multicentre study of an individual early warning score. Lancet Digit Health. 2022 Jul;4(7):e497-e506. doi: 10.1016/S2589-7500(22)00067-X. Epub 2022 May 19. Erratum In: Lancet Digit Health. 2022 Dec;4(12):e861.
- Nielsen PB, Schultz M, Langkjaer CS, Kodal AM, Pedersen NE, Petersen JA, Lange T, Arvig MD, Meyhoff CS, Bestle M, Holge-Hazelton B, Bunkenborg G, Lippert A, Andersen O, Rasmussen LS, Iversen KK. Adjusting Early Warning Score by clinical assessment: a study protocol for a Danish cluster-randomised, multicentre study of an Individual Early Warning Score (I-EWS). BMJ Open. 2020 Jan 7;10(1):e033676. doi: 10.1136/bmjopen-2019-033676.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 17017332
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Risk Stratification
-
Medical University InnsbruckCompleted
-
Singapore General HospitalCompletedPerioperative Medicine | Risk Stratification
-
Assistance Publique - Hôpitaux de ParisCompletedKidney Transplantation | Kidney Transplant Rejection | Prognosis | Risk StratificationFrance, Germany, Spain, Switzerland
-
Herlev HospitalCompletedTriage | Risk Stratification With BiomarkerDenmark
-
Mayo ClinicEsaote North AmericaCompletedCardiovascular Risk Stratification | Carotid Intima-media Thickness (CIMT) | Stress Echocardiography (SE)United States
-
University Hospital, Basel, SwitzerlandRecruitingTriage Risk StratificationSwitzerland
-
University Hospital, Basel, SwitzerlandCompletedTriage Risk StratificationSwitzerland
-
Bursa Sevket Yilmaz Training and Research HospitalNot yet recruitingPostoperative Complications | Coronary Artery Bypass Grafting | Postoperative Acute Kidney Injury | Risk StratificationTurkey (Türkiye)
-
Hua DuanRecruitingIntrauterine Adhesion | Database for Intrauterine Adhesion | Risk Factors for Intrauterine Adhesion | Risk Stratification and Prognostic AssessmentChina
-
Norwegian Institute of Public HealthVestre Viken Hospital Trust; Oslo University Hospital; University Hospital, Akershus and other collaboratorsNot yet recruitingBreast Cancer | Risk Stratification | Mammographic Breast Density
Clinical Trials on Standard EWS - Control (Trigger Tool)
-
Aarhus University HospitalUnknownPaediatric Early Warning SystemDenmark
-
Bedaya HospitalNot yet recruiting
-
University of British ColumbiaWellcome Trust; Kenya Medical Research InstituteCompleted
-
Riyadh Fertility and Reproductive Health centerUnknown
-
University of California, San FranciscoFerring PharmaceuticalsCompleted
-
Riyadh Fertility and Reproductive Health centerUnknownDouble Trigger in Patients With Low Number of Oocytes Retrieved Per Number of Preovulatory FolliclesInfertility, FemaleEgypt
-
University Hospitals, LeicesterCompletedArthrofibrosisUnited Kingdom
-
Mỹ Đức HospitalCompleted
-
University of Illinois at ChicagoNational Institute of Nursing Research (NINR)CompletedParenting | Fertility Issues | DisclosureUnited States
-
Duke UniversityEnrolling by invitationArthritis | Hip Fractures | Tibial Fractures | Femoroacetabular Impingement | Ankle Fractures | Osteochondritis DissecansUnited States